|
DE122011100031I1
(de)
*
|
1998-06-17 |
2011-12-15 |
Eisai R&D Man Co Ltd |
Makrocyclische analoga und verfahren zu ihrer verwendung und herstellung.
|
|
US8097648B2
(en)
*
|
1998-06-17 |
2012-01-17 |
Eisai R&D Management Co., Ltd. |
Methods and compositions for use in treating cancer
|
|
US6653341B1
(en)
*
|
1998-06-17 |
2003-11-25 |
Eisai Co., Ltd. |
Methods and compositions for use in treating cancer
|
|
DE10037310A1
(de)
|
2000-07-28 |
2002-02-07 |
Asta Medica Ag |
Neue Indolderivate und deren Verwendung als Arzneimittel
|
|
EP1531846A4
(de)
*
|
2002-02-27 |
2006-04-19 |
Us Gov Health & Human Serv |
Konjugate aus ligand, linker und zytotoxischem agens sowie verwandte zusammensetzungen und verwendungsverfahren
|
|
JP5042444B2
(ja)
|
2002-03-22 |
2012-10-03 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
癌の処置におけるヘミアスタリン誘導体およびその利用法
|
|
US20050075395A1
(en)
*
|
2003-05-28 |
2005-04-07 |
Gary Gordon |
Continuous dosing regimen
|
|
EP1644008B1
(de)
*
|
2003-05-29 |
2011-12-21 |
Abbott Laboratories |
Kontinuierliches dosierschema mit abt-751
|
|
WO2005011589A2
(en)
*
|
2003-07-29 |
2005-02-10 |
Eisai Co., Ltd. |
Drug delivery methods and devices
|
|
CN109180615A
(zh)
*
|
2004-06-03 |
2019-01-11 |
卫材R&D管理有限公司 |
用于制备软海绵素b的类似物的中间体
|
|
SI2522663T1
(sl)
|
2004-06-03 |
2015-08-31 |
Eisai R&D Management Co., Ltd. |
Vmesne spojine za pripravo halihondrina B
|
|
US20060045846A1
(en)
*
|
2004-08-30 |
2006-03-02 |
Horstmann Thomas E |
Reagents and methods for labeling terminal olefins
|
|
EP1831697A4
(de)
*
|
2004-12-09 |
2011-01-26 |
Eisai R&D Man Co Ltd |
Suche nach tubulinisotypen bei der krebstherapie unter verwendung von halichondrin-b-analogen
|
|
CN108948039B
(zh)
|
2007-10-03 |
2021-12-31 |
卫材R&D管理有限公司 |
用于合成软海绵素b类似物的中间体和方法
|
|
BRPI0911269A2
(pt)
*
|
2008-04-04 |
2015-09-29 |
Eisai R&D Man Co Ltd |
análogos de halicondrina b
|
|
BRPI1014527B8
(pt)
|
2009-03-30 |
2021-05-25 |
Eisai R&D Man Co Ltd |
composição farmacêutica na forma de lipossoma e método de fabricação da mesma
|
|
RU2476216C1
(ru)
*
|
2009-03-30 |
2013-02-27 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Липосомальная композиция
|
|
WO2010113983A1
(ja)
|
2009-03-30 |
2010-10-07 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
リポソーム組成物の製造方法
|
|
JP5556811B2
(ja)
*
|
2009-04-14 |
2014-07-23 |
日産化学工業株式会社 |
テトラヒドロピラン化合物の製造方法
|
|
BR112012018232B8
(pt)
|
2010-01-26 |
2023-01-10 |
Eisai R&D Man Co Ltd |
Compostos derivados de furo [3,2-b] pirano úteis na síntese de análogos de halicondrina b e métodos de sintetização de er-80402 e de eribulina
|
|
US9637795B2
(en)
|
2011-03-18 |
2017-05-02 |
Eisai R&D Management Co., Ltd. |
Methods and compositions for predicting response to eribulin
|
|
WO2012147900A1
(en)
|
2011-04-28 |
2012-11-01 |
Eisai R&D Management Co., Ltd. |
Microreactor process for halichondrin b analog synthesis
|
|
EP3444363B1
(de)
|
2011-06-03 |
2020-11-25 |
Eisai R&D Management Co., Ltd. |
Biomarker zur vorhersage und beurteilung des ansprechens von schilddrüsen- und nierenkrebspatienten auf lenvatinibverbindungen
|
|
JP2015500210A
(ja)
|
2011-11-30 |
2015-01-05 |
アルフォラ リサーチ インコーポレイテッドＡｌｐｈｏｒａ Ｒｅｓｅａｒｃｈ Ｉｎｃ． |
（３ｒ）−２，４−ジ−脱離基−３−メチルブタ−１−エンの調製方法
|
|
AU2012350420A1
(en)
|
2011-12-16 |
2014-07-10 |
Alphora Research Inc. |
Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl) propanol derivatives and intermediates useful thereof
|
|
CA2860446C
(en)
*
|
2011-12-29 |
2017-01-10 |
Alphora Research Inc. |
2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation
|
|
IN2014MN02106A
(de)
*
|
2012-03-30 |
2015-09-11 |
Alphora Res Inc |
|
|
US20140163095A1
(en)
|
2012-12-04 |
2014-06-12 |
Eisai R&D Management Co., Ltd. |
Use of eribulin in the treatment of breast cancer
|
|
TW201514159A
(zh)
|
2013-05-15 |
2015-04-16 |
Alphora Res Inc |
３-（（２ｓ，５ｓ）-４-亞甲基-５-（３-氧代丙基）四氫呋喃-２-基）丙醇衍生物、其製備及對其有用的中間體
|
|
EP3013335B1
(de)
|
2013-06-26 |
2018-11-07 |
Eisai R&D Management Co., Ltd. |
Kombinationstherapie zur behandlung von krebs enthaltend eribulin und lenvatinib
|
|
EP3016957A4
(de)
*
|
2013-07-03 |
2016-11-30 |
Alphora Res Inc |
Synthetisches verfahren zur herstellung von makrocyclischen c1-keto analoga von halichondrin b und dafür nützliche zwischenprodukte einschliesslich zwischenprodukten mit -so2-(p-tolyl)gruppen
|
|
CN103483352A
(zh)
*
|
2013-10-18 |
2014-01-01 |
李友香 |
抗肿瘤的药用原料药
|
|
CN114716453A
(zh)
|
2013-11-04 |
2022-07-08 |
卫材R&D管理有限公司 |
软海绵素b的类似物合成中有用的大环化反应和中间体
|
|
HUE043088T2
(hu)
|
2013-12-06 |
2019-08-28 |
Eisai R&D Man Co Ltd |
Halikondrin B analógok szintézisében alkalmazható eljárások
|
|
CN104860978A
(zh)
*
|
2014-02-20 |
2015-08-26 |
正大天晴药业集团股份有限公司 |
软海绵素b类似物的合成中间体
|
|
TW201617326A
(zh)
|
2014-03-06 |
2016-05-16 |
Ａｌｐｈｏｒａ研發股份有限公司 |
（ｓ）－１－（（２ｒ，３ｒ，４ｓ，５ｓ）－５－烯丙－３－甲氧－４－（對甲苯磺醯甲基）四氫呋喃－２－基）－３－氨基丙－２－醇之結晶衍生物
|
|
AU2015267099B2
(en)
|
2014-05-28 |
2020-08-27 |
Eisai R&D Management Co., Ltd |
Use of eribulin in the treatment of cancer
|
|
US10556910B2
(en)
*
|
2014-06-30 |
2020-02-11 |
President And Fellows Of Harvard College |
Synthesis of halichondrin analogs and uses thereof
|
|
LT3524595T
(lt)
|
2014-08-28 |
2022-09-26 |
Eisai R&D Management Co., Ltd. |
Aukšto grynumo chinolino darinys ir jo gamybos būdas
|
|
US10208058B2
(en)
|
2014-09-09 |
2019-02-19 |
Cipla Limited |
Process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts and intermediates thereof
|
|
CN105713031B
(zh)
*
|
2014-12-05 |
2021-05-07 |
正大天晴药业集团股份有限公司 |
一种用于制备艾日布林的中间体及其制备方法
|
|
RS65049B1
(sr)
|
2015-02-25 |
2024-02-29 |
Eisai R&D Man Co Ltd |
Metoda za suzbijanje gorčine derivata kinolina
|
|
BR112017018872A2
(pt)
|
2015-03-04 |
2018-05-29 |
Eisai R&D Man Co Ltd |
combinação de um antagonista pd-1 e eribulina para tratamento de câncer
|
|
WO2016140717A1
(en)
|
2015-03-04 |
2016-09-09 |
Merck Sharp & Dohme Corp. |
Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
|
|
WO2016176560A1
(en)
|
2015-04-30 |
2016-11-03 |
President And Fellows Of Harvard College |
Chromium-mediated coupling and application to the synthesis of halichondrins
|
|
US10308661B2
(en)
*
|
2015-05-07 |
2019-06-04 |
Eisai R&D Management Co., Ltd. |
Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides
|
|
US10597401B2
(en)
|
2015-05-08 |
2020-03-24 |
Albany Molecular Research, Inc. |
Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof
|
|
WO2016204193A1
(ja)
|
2015-06-16 |
2016-12-22 |
株式会社ＰＲＩＳＭ Ｐｈａｒｍａ |
抗がん剤
|
|
MX2018009794A
(es)
|
2016-02-12 |
2018-12-17 |
Eisai R&D Man Co Ltd |
Intermediarios en la sintesis de eribulina y metodos de sintesis relacionados.
|
|
ES2952680T3
(es)
|
2016-04-28 |
2023-11-03 |
Eisai R&D Man Co Ltd |
Eribulina para inhibir el crecimiento tumoral
|
|
CN109415383A
(zh)
*
|
2016-05-26 |
2019-03-01 |
雷迪博士实验室有限公司 |
制备艾日布林的方法及其中间体
|
|
EP3478691A4
(de)
|
2016-06-30 |
2020-07-22 |
Eisai R&D Management Co., Ltd. |
Prins-reaktion und zwischenprodukte für die synthese von halichondrinmakroliden und analoga davon
|
|
BR112019007145A2
(pt)
|
2016-10-14 |
2019-07-02 |
Eisai R&D Man Co Ltd |
combinação de um antagonista de pd-1 e eribulina para o tratamento de câncer urotelial
|
|
JP6978758B2
(ja)
|
2016-11-11 |
2021-12-08 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
パラジウム媒介ケトール化
|
|
US10836776B2
(en)
|
2016-11-23 |
2020-11-17 |
Dr. Reddy's Laboratories Limited |
Process for preparation of eribulin and intermediates thereof
|
|
KR101991710B1
(ko)
|
2017-12-14 |
2019-06-21 |
연성정밀화학(주) |
에리불린 메실산염의 제조 중간체 및 그의 제조방법
|
|
US10865212B2
(en)
|
2017-01-02 |
2020-12-15 |
Yonsung Fine Chemical Co.. Ltd. |
Intermediate for preparing eribulin mesylate and process for preparing the same
|
|
KR101880939B1
(ko)
|
2017-01-02 |
2018-08-17 |
연성정밀화학(주) |
에리불린 메실산염의 제조 중간체 및 그의 제조방법
|
|
CN108341738B
(zh)
*
|
2017-01-24 |
2022-10-21 |
江苏恒瑞医药股份有限公司 |
用于制备艾日布林的方法及其中间体
|
|
CN108341828B
(zh)
*
|
2017-01-24 |
2021-04-06 |
江苏恒瑞医药股份有限公司 |
用于制备艾日布林的方法及其中间体
|
|
US9938288B1
(en)
|
2017-04-05 |
2018-04-10 |
President And Fellows Of Harvard College |
Macrocyclic compound and uses thereof
|
|
MA48027B1
(fr)
|
2017-04-05 |
2022-12-30 |
Harvard College |
Composé macrocyclique et utilisations de celui-ci
|
|
HUE061306T2
(hu)
|
2017-07-06 |
2023-06-28 |
Harvard College |
Halikondrinok szintézise
|
|
US11498892B2
(en)
|
2017-07-06 |
2022-11-15 |
President And Fellows Of Harvard College |
Fe/Cu-mediated ketone synthesis
|
|
US20190046513A1
(en)
|
2017-08-10 |
2019-02-14 |
Huya Bioscience International, Llc |
Combination therapies of hdac inhibitors and tubulin inhibitors
|
|
CN109694379B
(zh)
*
|
2017-10-24 |
2020-09-11 |
江苏恒瑞医药股份有限公司 |
用于制备艾日布林的中间体及其制备方法
|
|
JP6967811B2
(ja)
*
|
2017-11-09 |
2021-11-17 |
ヨンスン ファイン ケミカル カンパニー，リミテッド |
エリブリンメシル酸塩の製造中間体及びその製造方法
|
|
ES2974243T3
(es)
|
2017-11-15 |
2024-06-26 |
Harvard College |
Compuestos macrocíclicos y usos de los mismos
|
|
WO2019097073A1
(en)
|
2017-11-20 |
2019-05-23 |
Basilea Pharmaceutica International AG |
Pharmaceutical combinations for use in the treatment of neoplastic diseases
|
|
WO2019102490A1
(en)
|
2017-11-21 |
2019-05-31 |
Natco Pharma Limited |
Intermediates for the preparation of eribulin thereof
|
|
IL275729B2
(en)
|
2018-01-03 |
2023-09-01 |
Eisai R&D Man Co Ltd |
Prins reaction and compounds useful in the synthesis of helicondrin macrolides and their analogs
|
|
WO2019211877A1
(en)
|
2018-05-03 |
2019-11-07 |
Cipla Limited |
Process for the preparation of macrocyclic ketone analogs of halichondrin b
|
|
WO2020008382A1
(en)
*
|
2018-07-04 |
2020-01-09 |
Dr. Reddy’S Laboratories Limited |
Process for preparation of eribulin and intermediates thereof
|
|
CN112437775A
(zh)
*
|
2018-07-20 |
2021-03-02 |
雷迪博士实验室有限公司 |
用于制备艾日布林及其中间体的纯化方法
|
|
EP3864011A4
(de)
*
|
2018-10-09 |
2022-06-29 |
Dr. Reddy's Laboratories Ltd. |
Verfahren zur herstellung von eribulin und zwischenprodukten davon
|
|
US11447499B2
(en)
|
2019-06-14 |
2022-09-20 |
Rk Pharma Inc. |
Process for the preparation of eribulin mesylate intermediate
|
|
WO2020255164A1
(en)
|
2019-06-21 |
2020-12-24 |
Council Of Scientific And Industrial Research |
A chemo-enzymatic process for the preparation of homopropargylic alcohol
|
|
US12036204B2
(en)
|
2019-07-26 |
2024-07-16 |
Eisai R&D Management Co., Ltd. |
Pharmaceutical composition for treating tumor
|
|
US11083705B2
(en)
|
2019-07-26 |
2021-08-10 |
Eisai R&D Management Co., Ltd. |
Pharmaceutical composition for treating tumor
|
|
KR20220095197A
(ko)
|
2019-11-07 |
2022-07-06 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
항-메소텔린 에리불린 항체-약물 컨쥬게이트 및 이용 방법
|
|
CN113135876B
(zh)
*
|
2020-01-16 |
2024-05-17 |
南通诺泰生物医药技术有限公司 |
艾日布林及其中间体的制备方法
|
|
AU2021210079A1
(en)
*
|
2020-01-22 |
2022-08-25 |
Jiangsu Hengrui Medicine Co., Ltd. |
Drug conjugate of Eribulin derivative, preparation method therefor and application thereof in medicine
|
|
KR102377262B1
(ko)
|
2020-05-11 |
2022-03-22 |
연성정밀화학(주) |
결정성 에리불린 염
|
|
IL279168B
(en)
*
|
2020-12-02 |
2022-04-01 |
Finetech Pharmaceutical Ltd |
A process for the preparation of eribulin
|
|
CN113354659B
(zh)
|
2021-06-08 |
2022-04-08 |
江苏慧聚药业股份有限公司 |
甲磺酸艾日布林的合成
|
|
EP4374879A1
(de)
*
|
2021-07-22 |
2024-05-29 |
Shanghai Senhui Medicine Co., Ltd. |
Wirkstoffkonjugat aus eribulinderivat
|
|
WO2023212746A2
(en)
*
|
2022-04-30 |
2023-11-02 |
William Marsh Rice University |
A unified strategy for the total syntheses of eribulin and a macrolactam analogue of halichondrin b
|
|
CN118356507A
(zh)
*
|
2023-01-17 |
2024-07-19 |
成都百利多特生物药业有限责任公司 |
一种艾日布林类药物的偶联物
|